We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cloudtag | LSE:CTAG | London | Ordinary Share | KYG2215A1076 | ORD 0.1P (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.875 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
11/8/2017 13:40 | Good afternoon all. Andy | saul goodman | |
11/8/2017 13:39 | Good afternoon all. Tom | avatar333 | |
09/8/2017 07:46 | Good morning all. Andy. | saul goodman | |
08/8/2017 23:38 | Bahv Dattani, Head of Sales for Cloudtag since September 2016Previously Head of Sales UK for JawboneIn fairness, he has had nothing to sell at Cloudtag and needs to make a crust somehow.I'm looking forward to reading the Aberdeen Uni research. | nod | |
08/8/2017 13:32 | Shareholder update regarding recent pre-clinical study. 8th August 2017 CloudTag (CTAG:LN), the company that brings personal monitoring to the wellbeing, fitness and digital health markets, is pleased to share some initial insights and findings from its recent pre-clinical study. The Onitor pilot pre-clinical study which was led from the University of Aberdeen has been completed and is being written up, including quantitative and qualitative outcomes, including theories of behavioural change. The draft report has now been submitted for publication as a mixed methods digital health study by the researchers and authors, Kelly Buchan and Heather Morgan. This will undergo the requisite process of scientific peer review prior to being made publicly available. Amit Ben-Haim, CEO, said “As part of our ongoing strategy to focus on the clinical benefit of our products, we are enthused by the early results of this study, which bode very positively for the development of our proprietary hardware and software Cloudtag Inc. Amit Ben-Haim +1 345 949 45 44 contact@cloudtag.com UK Investor Relations. +44 (0) 20 7052 8469 investors@cloudtag.c | bbmsionlypostafter | |
08/8/2017 13:23 | Good afternoon all. Andy | saul goodman | |
03/8/2017 09:55 | Good morning all. Andy | saul goodman | |
03/8/2017 09:54 | Good morning all. Tom | avatar333 | |
02/8/2017 08:58 | Good morning all. Andy | saul goodman | |
02/8/2017 08:51 | Good morning all. Stretch | stretch armstrong | |
02/8/2017 08:43 | Good morning all. Tom | avatar333 | |
01/8/2017 09:42 | #201 Duly noted with thanks. Andy | saul goodman | |
01/8/2017 09:42 | Good morning all. Andy. | saul goodman | |
01/8/2017 09:29 | Nope, not much at all. A further observation: The beginning of August ends around the middle of August. Stretch | stretch armstrong | |
31/7/2017 14:48 | There is not much gets past you, Stretch. Andy | saul goodman | |
31/7/2017 14:41 | Good afternoon all. Not long until the beginning of August I see. Stretch | stretch armstrong | |
31/7/2017 11:25 | Good morning all. Andy | saul goodman | |
28/7/2017 09:02 | Good morning all. Andy | saul goodman | |
28/7/2017 08:48 | Good morning all. Tom | avatar333 | |
27/7/2017 09:57 | Good morning all. Andy | saul goodman | |
27/7/2017 09:50 | Good morning all. Tom | avatar333 | |
26/7/2017 08:37 | Good morning all. Tom | avatar333 | |
26/7/2017 08:36 | Good morning all. Andy | saul goodman |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions